Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Johnson & Johnson (JNJ)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Johnson & Johnson.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 200406.
Total stock buying since 2015: $2,435,223.
Total stock sales since 2015: $413,300,517.
Total stock option exercises since 2015: $259,720,439.
Table 3. Detailed insider trading at Johnson & Johnson (JNJ) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2021-02-12 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 13,606 | .00 | 0 |
| 2021-02-12 | Mcevoy Ashley (EVP, WW Chair, Medical Devices) | Option Ex | 13,136 | .00 | 0 |
| 2021-02-12 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 5,086 | .00 | 0 |
| 2021-02-12 | Duato Joaquin (Vice Chair, Exec Committee) | Option Ex | 33,021 | .00 | 0 |
| 2021-02-12 | Stoffels Paulus (Vice Chair, Exec Committee) | Option Ex | 35,062 | .00 | 0 |
| 2021-02-12 | Ullmann Michael H (Exec VP, General Counsel) | Option Ex | 14,444 | .00 | 0 |
| 2021-02-12 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 12,873 | .00 | 0 |
| 2021-02-12 | Gorsky Alex (Chairman, CEO) | Option Ex | 75,105 | .00 | 0 |
| 2020-12-09 | Sneed Michael E (EVP, Global Corp Aff & COO) | Sale | 54,662 | 152.93 | 8,359,459 |
| 2020-12-09 | Sneed Michael E (EVP, Global Corp Aff & COO) | Option Ex | 54,662 | 62.20 | 3,399,976 |
| 2020-09-02 | Wengel Kathryn E (EVP, Chief GSC Officer) | Sale | 16,115 | 153.52 | 2,473,926 |
| 2020-09-02 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 16,115 | 63.78 | 1,027,895 |
| 2020-07-28 | Mcevoy Ashley (EVP, WW Chair, Medical Devices) | Sale | 29,000 | 147.47 | 4,276,630 |
| 2020-03-13 | Perez William D (Director) | Buy | 500 | 127.69 | 63,843 |
| 2020-02-21 | Mongon Thibaut (Exec VP, WW Chair, Consumer) | Sale | 39,224 | 147.96 | 5,803,583 |
| 2020-02-21 | Mongon Thibaut (Exec VP, WW Chair, Consumer) | Option Ex | 19,224 | 90.44 | 1,738,618 |
| 2020-02-13 | Decker Robert J (Controller, CAO) | Option Ex | 1,499 | .00 | 0 |
| 2020-02-13 | Mongon Thibaut (Exec VP, WW Chair, Consumer) | Option Ex | 3,692 | .00 | 0 |
| 2020-02-13 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 15,809 | .00 | 0 |
| 2020-02-13 | Sneed Michael E (EVP, Global Corp Aff & COO) | Option Ex | 11,836 | .00 | 0 |
| 2020-02-13 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 16,084 | .00 | 0 |
| 2020-02-13 | Mcevoy Ashley (EVP, WW Chair, Medical Devices) | Option Ex | 13,747 | .00 | 0 |
| 2020-02-13 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 7,080 | .00 | 0 |
| 2020-02-13 | Duato Joaquin (Vice Chair, Exec Committee) | Option Ex | 105,668 | .00 | 0 |
| 2020-02-13 | Stoffels Paulus (Vice Chair, Exec Committee) | Option Ex | 39,381 | .00 | 0 |
| 2020-02-13 | Ullmann Michael H (Exec VP, General Counsel) | Option Ex | 20,326 | .00 | 0 |
| 2020-02-13 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 22,231 | .00 | 0 |
| 2020-02-13 | Gorsky Alex (Chairman, CEO) | Option Ex | 107,016 | .00 | 0 |
| 2020-02-03 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 48,312 | .00 | 0 |
| 2020-02-03 | Mcevoy Ashley (EVP, WW Chair, Medical Devices) | Option Ex | 38,650 | .00 | 0 |
| 2020-01-30 | Sneed Michael E (EVP, Global Corp Aff & COO) | Sale | 58,128 | 149.39 | 8,683,567 |
| 2020-01-30 | Sneed Michael E (EVP, Global Corp Aff & COO) | Option Ex | 58,128 | 62.62 | 3,639,975 |
| 2019-12-13 | Joly Hubert (Director) | Buy | 5,000 | 141.28 | 706,400 |
| 2019-12-12 | Wengel Kathryn E (EVP, Chief GSC Officer) | Sale | 2,017 | 141.07 | 284,538 |
| 2019-12-12 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 2,017 | 62.62 | 126,304 |
| 2019-06-11 | Hewson Marillyn A (Director) | Buy | 3,000 | 139.68 | 419,040 |
| 2019-02-11 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 6,722 | .00 | 0 |
| 2019-02-11 | Sneed Michael E (EVP, Global Corp Aff & COO) | Option Ex | 7,275 | .00 | 0 |
| 2019-02-11 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 9,748 | .00 | 0 |
| 2019-02-11 | Mcevoy Ashley (EVP, WW Chair, Medical Devices) | Option Ex | 7,541 | .00 | 0 |
| 2019-02-11 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 2,903 | .00 | 0 |
| 2019-02-11 | Duato Joaquin (Vice Chair, Exec Committee) | Option Ex | 22,624 | .00 | 0 |
| 2019-02-11 | Kapusta Ronald A (Controller, CAO) | Option Ex | 2,839 | .00 | 0 |
| 2019-02-11 | Stoffels Paulus (Vice Chair, Exec Committee) | Option Ex | 31,428 | .00 | 0 |
| 2019-02-11 | Mesquita Jorge S. (Exec VP, WW Chair, Consumer) | Option Ex | 16,968 | .00 | 0 |
| 2019-02-11 | Ullmann Michael H (Exec VP, General Counsel) | Option Ex | 13,273 | .00 | 0 |
| 2019-02-11 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 12,609 | .00 | 0 |
| 2019-02-11 | Gorsky Alex (Chairman, CEO) | Option Ex | 73,947 | .00 | 0 |
| 2019-02-08 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 5,882 | .00 | 0 |
| 2019-02-08 | Sneed Michael E (EVP, Global Corp Aff & COO) | Option Ex | 6,365 | .00 | 0 |
| 2019-02-08 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 8,529 | .00 | 0 |
| 2019-02-08 | Mcevoy Ashley (EVP, WW Chair, Medical Devices) | Option Ex | 6,599 | .00 | 0 |
| 2019-02-08 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 2,540 | .00 | 0 |
| 2019-02-08 | Duato Joaquin (Vice Chair, Exec Committee) | Option Ex | 9,049 | .00 | 0 |
| 2019-02-08 | Kapusta Ronald A (Controller, CAO) | Option Ex | 2,484 | .00 | 0 |
| 2019-02-08 | Stoffels Paulus (Vice Chair, Exec Committee) | Option Ex | 12,571 | .00 | 0 |
| 2019-02-08 | Mesquita Jorge S. (Exec VP, WW Chair, Consumer) | Option Ex | 6,787 | .00 | 0 |
| 2019-02-08 | Ullmann Michael H (Exec VP, General Counsel) | Option Ex | 5,309 | .00 | 0 |
| 2019-02-08 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 5,044 | .00 | 0 |
| 2019-02-08 | Gorsky Alex (Chairman, CEO) | Option Ex | 29,579 | .00 | 0 |
| 2018-12-14 | Prince Charles (Director) | Buy | 2,000 | 134.37 | 268,732 |
| 2018-12-14 | Mulcahy Anne M (Director) | Buy | 748 | 133.76 | 100,050 |
| 2018-12-14 | Perez William D (Director) | Buy | 1,000 | 133.91 | 133,910 |
| 2018-12-13 | Kapusta Ronald A (Controller, CAO) | Sale | 3,643 | 147.31 | 536,639 |
| 2018-12-04 | Fasolo Peter (Exec VP, Chief HR Officer) | Sale | 41,563 | 146.68 | 6,096,543 |
| 2018-12-04 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 41,563 | 95.25 | 3,958,875 |
| 2018-12-03 | Fasolo Peter (Exec VP, Chief HR Officer) | Sale | 125,132 | 146.31 | 18,308,688 |
| 2018-12-03 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 125,132 | 95.25 | 11,918,823 |
| 2018-11-23 | Sneed Michael E (EVP, Global Corp Aff & COO) | Sale | 30,943 | 142.46 | 4,407,985 |
| 2018-11-23 | Sneed Michael E (EVP, Global Corp Aff & COO) | Option Ex | 30,943 | 58.33 | 1,804,905 |
| 2018-11-16 | Gorsky Alex (Chairman, CEO) | Sale | 264,465 | 145.96 | 38,601,046 |
| 2018-11-16 | Gorsky Alex (Chairman, CEO) | Option Ex | 264,465 | 62.41 | 16,505,260 |
| 2018-11-08 | Kapusta Ronald A (Controller, CAO) | Sale | 8,441 | 145.15 | 1,225,202 |
| 2018-11-07 | Duato Joaquin (Vice Chair, Exec Committee) | Sale | 40,000 | 144.36 | 5,774,480 |
| 2018-11-07 | Duato Joaquin (Vice Chair, Exec Committee) | Option Ex | 40,000 | 61.97 | 2,478,680 |
| 2018-09-07 | Kapusta Ronald A (Controller, CAO) | Sale | 7,899 | 137.18 | 1,083,608 |
| 2018-08-27 | Sneed Michael E (EVP, Global Corp Aff & COO) | Sale | 29,000 | 134.80 | 3,909,084 |
| 2018-08-27 | Sneed Michael E (EVP, Global Corp Aff & COO) | Option Ex | 29,000 | 58.33 | 1,691,570 |
| 2018-02-15 | Stoffels Paulus (Exec VP, Chief Scientific Officer) | Sale | 155,342 | 129.86 | 20,172,401 |
| 2018-02-15 | Stoffels Paulus (Exec VP, Chief Scientific Officer) | Option Ex | 155,342 | 90.44 | 14,049,130 |
| 2018-02-09 | Duato Joaquin (Exec VP, WW Chair, Pharma) | Option Ex | 9,812 | .00 | 0 |
| 2018-02-09 | Kapusta Ronald A (Controller, CAO) | Option Ex | 2,702 | .00 | 0 |
| 2018-02-09 | Stoffels Paulus (Exec VP, Chief Scientific Officer) | Option Ex | 13,252 | .00 | 0 |
| 2018-02-09 | Ullmann Michael H (Exec VP, General Counsel) | Option Ex | 5,953 | .00 | 0 |
| 2018-02-09 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 5,830 | .00 | 0 |
| 2018-02-09 | Gorsky Alex (Chairman, CEO) | Option Ex | 33,165 | .00 | 0 |
| 2018-02-09 | Caruso Dominic J (Exec VP, Finance; CFO) | Option Ex | 10,601 | .00 | 0 |
| 2018-02-09 | Peterson Sandra E (Exec VP, Group WW Chairman) | Option Ex | 11,445 | .00 | 0 |
| 2018-02-02 | Mesquita Jorge S. (Exec VP, WW Chair, Consumer) | Option Ex | 32,688 | .00 | 0 |
| 2017-10-31 | Stoffels Paulus (Exec VP, Chief Scientific Officer) | Option Ex | 75,492 | .00 | 0 |
| 2017-07-24 | Stoffels Paulus (Exec VP, Chief Scientific Officer) | Sale | 102,692 | 133.14 | 13,672,618 |
| 2017-07-24 | Stoffels Paulus (Exec VP, Chief Scientific Officer) | Option Ex | 102,692 | 72.54 | 7,449,277 |
| 2017-07-20 | Caruso Dominic J (Exec VP, Finance; CFO) | Sale | 82,591 | 136.72 | 11,291,511 |
| 2017-07-20 | Caruso Dominic J (Exec VP, Finance; CFO) | Option Ex | 82,591 | 61.75 | 5,099,994 |
| 2017-03-03 | Duato Joaquin (Exec VP, WW Chair, Pharma) | Sale | 50,000 | 123.62 | 6,181,150 |
| 2017-03-03 | Duato Joaquin (Exec VP, WW Chair, Pharma) | Option Ex | 50,000 | 60.04 | 3,002,000 |
| 2017-02-28 | Pruden Gary J (Exec VP, WW Chair, Med Devices) | Sale | 16,299 | 122.21 | 1,991,949 |
| 2017-02-28 | Kapusta Ronald A (Controller, CAO) | Sale | 14,543 | 122.25 | 1,777,954 |
| 2017-02-28 | Kapusta Ronald A (Controller, CAO) | Option Ex | 14,543 | 72.54 | 1,054,949 |
| 2017-02-15 | Stoffels Paulus (Exec VP, Chief Scientific Officer) | Sale | 22,000 | 117.28 | 2,580,270 |
| 2017-02-13 | Pruden Gary J (Exec VP, WW Chair, Med Devices) | Option Ex | 15,532 | .00 | 0 |
| 2017-02-13 | Duato Joaquin (Exec VP, WW Chair, Pharma) | Option Ex | 22,298 | .00 | 0 |
| 2017-02-13 | Kapusta Ronald A (Controller, CAO) | Option Ex | 2,148 | .00 | 0 |
| 2017-02-13 | Stoffels Paulus (Exec VP, Chief Scientific Officer) | Option Ex | 26,447 | .00 | 0 |
| 2017-02-13 | Ullmann Michael H (Exec VP, General Counsel) | Option Ex | 14,600 | .00 | 0 |
| 2017-02-13 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 15,598 | .00 | 0 |
| 2017-02-13 | Gorsky Alex (Chairman, CEO) | Option Ex | 84,299 | .00 | 0 |
| 2017-02-13 | Caruso Dominic J (Exec VP, Finance; CFO) | Option Ex | 26,947 | .00 | 0 |
| 2017-02-13 | Peterson Sandra E (Exec VP, Group WW Chairman) | Option Ex | 27,667 | .00 | 0 |
| 2017-02-01 | Ullmann Michael H (Exec VP, General Counsel) | Sale | 21,735 | 112.88 | 2,453,446 |
| 2017-02-01 | Ullmann Michael H (Exec VP, General Counsel) | Option Ex | 27,735 | 65.62 | 1,819,970 |
| 2016-10-21 | Prince Charles (Director) | Buy | 875 | 114.11 | 99,846 |
| 2016-07-26 | Caruso Dominic J (Exec VP, Finance; CFO) | Sale | 41,146 | 125.01 | 5,143,826 |
| 2016-07-26 | Caruso Dominic J (Exec VP, Finance; CFO) | Option Ex | 41,146 | 65.62 | 2,700,000 |
| 2016-07-22 | Kapusta Ronald A (Controller, CAO) | Sale | 2,935 | 125.01 | 366,895 |
| 2016-07-21 | Kapusta Ronald A (Controller, CAO) | Option Ex | 2,935 | 58.33 | 171,198 |
| 2016-06-07 | Pruden Gary J (Exec VP, WW Chair, Med Devices) | Sale | 9,735 | 116.03 | 1,129,552 |
| 2016-06-07 | Kapusta Ronald A (Controller, CAO) | Sale | 3,000 | 115.79 | 347,382 |
| 2016-06-07 | Kapusta Ronald A (Controller, CAO) | Option Ex | 3,000 | 58.33 | 174,990 |
| 2016-05-10 | Kapusta Ronald A (Controller, CAO) | Sale | 3,957 | 114.77 | 454,156 |
| 2016-05-10 | Kapusta Ronald A (Controller, CAO) | Option Ex | 3,957 | 58.33 | 230,811 |
| 2016-02-08 | Kapusta Ronald A (Controller, CAO) | Option Ex | 2,598 | .00 | 0 |
| 2016-02-08 | Stoffels Paulus (Chief Scientific Officer) | Option Ex | 28,242 | .00 | 0 |
| 2016-02-08 | Ullmann Michael H (VP, General Counsel) | Option Ex | 16,697 | .00 | 0 |
| 2016-02-08 | Fasolo Peter (VP, Global Human Resources) | Option Ex | 18,777 | .00 | 0 |
| 2016-02-08 | Gorsky Alex (Chairman, CEO) | Option Ex | 67,933 | .00 | 0 |
| 2016-02-08 | Caruso Dominic J (VP, Finance; CFO) | Option Ex | 29,005 | .00 | 0 |
| 2016-02-08 | Peterson Sandra E (Group Worldwide Chairman) | Option Ex | 7,633 | .00 | 0 |
| 2016-02-03 | Fasolo Peter (VP, Global Human Resources) | Sale | 144,568 | 104.12 | 15,052,420 |
| 2016-02-03 | Fasolo Peter (VP, Global Human Resources) | Option Ex | 144,568 | 72.54 | 10,486,962 |
| 2016-02-02 | Fasolo Peter (VP, Global Human Resources) | Sale | 6,817 | 104.09 | 709,588 |
| 2016-02-02 | Fasolo Peter (VP, Global Human Resources) | Option Ex | 6,817 | 72.54 | 494,505 |
| 2016-01-15 | Kapusta Ronald A (Controller, CAO) | Option Ex | 3,896 | .00 | 0 |
| 2016-01-15 | Stoffels Paulus (Chief Scientific Officer) | Option Ex | 11,297 | .00 | 0 |
| 2016-01-15 | Ullmann Michael H (VP, General Counsel) | Option Ex | 6,679 | .00 | 0 |
| 2016-01-15 | Fasolo Peter (VP, Global Human Resources) | Option Ex | 7,511 | .00 | 0 |
| 2016-01-15 | Gorsky Alex (Chairman, CEO) | Option Ex | 27,173 | .00 | 0 |
| 2016-01-15 | Caruso Dominic J (VP, Finance; CFO) | Option Ex | 11,602 | .00 | 0 |
| 2016-01-15 | Peterson Sandra E (Group Worldwide Chairman) | Option Ex | 3,053 | .00 | 0 |
| 2015-12-17 | Peterson Sandra E (Group Worldwide Chairman) | Option Ex | 21,688 | .00 | 0 |
| 2015-11-20 | Ullmann Michael H (VP, General Counsel) | Sale | 17,650 | 102.47 | 1,808,542 |
| 2015-11-20 | Ullmann Michael H (VP, General Counsel) | Option Ex | 22,626 | 58.34 | 1,320,000 |
| 2015-11-02 | Caruso Dominic J (VP, Finance; CFO) | Sale | 20,569 | 102.21 | 2,102,419 |
| 2015-11-02 | Caruso Dominic J (VP, Finance; CFO) | Option Ex | 20,569 | 58.34 | 1,199,995 |
| 2015-10-23 | Kapusta Ronald A (Controller, CAO) | Sale | 6,239 | 99.68 | 621,903 |
| 2015-10-23 | Kapusta Ronald A (Controller, CAO) | Option Ex | 6,239 | 58.34 | 363,983 |
| 2015-08-06 | Prince Charles (Director) | Buy | 2,500 | 99.25 | 248,132 |
| 2015-06-02 | Prince Charles (Director) | Buy | 2,500 | 99.22 | 248,050 |
| 2015-03-05 | Fasolo Peter (VP, Global Human Resources) | Sale | 115,307 | 102.40 | 11,807,898 |
| 2015-03-05 | Fasolo Peter (VP, Global Human Resources) | Option Ex | 115,307 | 65.37 | 7,537,618 |
| 2015-02-09 | Stoffels Paulus (Chief Scientific Officer) | Option Ex | 29,073 | .00 | 0 |
| 2015-02-09 | Fasolo Peter (VP, Global Human Resources) | Option Ex | 20,935 | .00 | 0 |
| 2015-02-09 | Gorsky Alex (Chairman, CEO) | Option Ex | 42,112 | .00 | 0 |
| 2015-02-09 | Caruso Dominic J (VP, Finance; CFO) | Option Ex | 31,537 | .00 | 0 |
| 2015-01-16 | Stoffels Paulus (Chief Scientific Officer) | Option Ex | 11,629 | .00 | 0 |
| 2015-01-16 | Ullmann Michael H (VP, General Counsel) | Option Ex | 8,949 | .00 | 0 |
| 2015-01-16 | Fasolo Peter (VP, Global Human Resources) | Option Ex | 8,374 | .00 | 0 |
| 2015-01-16 | Gorsky Alex (Chairman, CEO) | Option Ex | 16,845 | .00 | 0 |
| 2015-01-16 | Caruso Dominic J (VP, Finance; CFO) | Option Ex | 12,615 | .00 | 0 |
| 2015-01-16 | Cosgrove Stephen J (Corporate Controller) | Option Ex | 11,108 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
of JNJ listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Johnson & Johnson (symbol JNJ,
CIK number 200406) see
the Securities and Exchange Commission (SEC) website.